Corrigendum: The citrus flavanone naringenin impairs dengue virus replication in human cells (Scientific Reports (2017) 7 (41864) DOI: 10.1038/srep41864);The citrus flavanone naringenin impairs dengue virus replication in human cells

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Frabasile, Sandra ^a,b   Koishi, Andrea Cristine ^b   Kuczera, Diogo ^b   Silveira, Guilherme Ferreira ^b   Verri, Waldiceu Aparecido ^c   Dos Santos, Claudia Nunes Duarte ^a   Bordignon, Juliano ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVANONE DERIVATIVE; NARINGENIN;

CELL LINE; DENGUE VIRUS; DRUG EFFECT; HUMAN; PHYSIOLOGY; VIRUS REPLICATION;

CELL LINE; DENGUE VIRUS; FLAVANONES; HUMANS; VIRUS REPLICATION;

EID: 85011534512     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43976     Document Type: Erratum

References (47)

1. WHO. Dengue: guidelines for diagnosis, treatment, prevention, and control. Spec. Program. Res. Train. Trop. Dis. 147, doi: WHO/HTM/NTD/DEN/2009.1 (2009).
2. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
3. Henchal, E. A. & Putnak, J. R. The Dengue Viruses. Clinical Microbiology Reviews 3, 376-396 (1990).
4. Chambers, T. J., Hahn, C. S., Galler, R. & Rice, C. M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44, 649-688 (1990).
5. Hadinegoro, S. R. et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N. Engl. J. Med. 373, 1195-1206 (2015).
6. Jassim, S. A. A. & Naji, M. A. Novel antiviral agents: A medicinal plant perspective. J. Appl. Microbiol. 95, 412-427 (2003).
7. Cushnie, T. P. T. & Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26, 343-356 (2005).
8. Debiaggi, M., Tateo, F., Pagani, L., Luini, M. & Romero, E. Effects of propolis flavonoids on virus infectivity and replication. Microbiologica 13, 207-213 (1990).
9. Lyu, S.-Y., Rhim, J.-Y. & Park, W.-B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28, 1293-1301 (2005).
10. Matias, A. a. et al. Portuguese winemaking residues as a potential source of natural anti-adenoviral agents. Int. J. Food Sci. Nutr. 61, 357-368 (2010).
11. Kwon, H. J. et al. In vitro anti-rotavirus activity of polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorganic Med. Chem. 18, 7668-7674 (2010).
12. Zandi, K., Teoh, B., Sam, S., Wong, P. & Mustafa, M. R. In vitro antiviral activity of Fisetin, Rutin and Naringenin against Dengue virus type-2. J. Med. Plants Res. 5, 5534-5539 (2011).
13. Su, X. & D'Souza, D. H. Naturally Occurring Flavonoids Against Human Norovirus Surrogates. Food Environ. Virol. 5, 97-102 (2013).
14. Grienke, U. et al. Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Sci. Rep. 6, 27156 (2016).
15. Verri, W. A. et al. Flavonoids as anti-inflammatory and analgesic drugs: Mechanisms of action and perspectives in the development of pharmaceutical forms. Stud. Nat. Prod. Chem. 36, 297-330 (2012).
16. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32, 1141-1148 (1983).
17. Middleton, E. & Kandaswami, C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. The flavonoids-Advances in research since 1986, doi: 10.1007/978-1-4899-2911-2-15 (Springer, US, 1993).
18. Grange, J. M. & Davey, R. W. Antibacterial properties of propolis (bee glue). J. R. Soc. Med. 83, 159-60 (1990).
19. Harborne, J. B. & Baxter, H. Handbook of Natural Flavonoids (1999).
20. Havsteen, B. H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96, 67-202 (2002).
21. Pinho-Ribeiro, F. A. et al. Naringenin reduces inflammatory pain in mice. Neuropharmacology 105, 508-519 (2016).
22. Pinho-Ribeiro, F. A. et al. The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κ B activation. J. Nutr. Biochem. 33, 8-14 (2016).
23. Lulu, S. S., Thabitha, a., Vino, S., Priya, a. M. & Rout, M. Naringenin and quercetin - potential anti-HCV agents for NS2 protease targets. Natural Product Research 30(4), 464-8 (2016).
24. Cotin, S. et al. Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antiviral Res. 96, 181-6 (2012).
25. Repetto, G., del Peso, A. & Zurita, J. L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 3, 1125-31 (2008).
26. Koishi, A. C., Zanello, P. R., Bianco, É. M. & Bordignon, J. & Nunes Duarte dos Santos, C. Screening of Dengue Virus Antiviral Activity of Marine Seaweeds by an In Situ Enzyme-Linked Immunosorbent Assay. PLoS One 7 (2012).
27. Suzuki, R., de Borba, L., Duarte dos Santos, C. N. & Mason, P. W. Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: Characterization of a temperature-sensitive mutation in NS1. Virology 362, 374-383 (2007).
28. Mosimann, A. L. P., de Borba, L., Bordignon, J., Mason, P. W. & Santos, C. N. D. dos. Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02). J. Virol. Methods 163, 147-152 (2010).
29. Li, B. Q. et al. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem. Biophys. Res. Commun. 276, 534-538 (2000).
30. Lani, R. et al. Antiviral activity of selected flavonoids against Chikungunya virus. Antiviral Res. 133, 50-61 (2016).
31. Pohjala, L. et al. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One 6 (2011).
32. Khachatoorian, R. et al. Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle. Virology 433, 346-355 (2012).
33. Zanello, P. R. et al. Quinic acid derivatives inhibit dengue virus replication in vitro. Virol. J. 1-13, doi: 10.1186/s12985-015-0443-9 (2015).
34. de Burghgraeve, T. et al. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. PLoS One 7, 1-9 (2012).
35. Kato, F. et al. Novel antiviral activity of bromocriptine against dengue virus replication. Antiviral Res. 131, 141-147 (2016).
36. de Sousa, L. R. F. et al. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorg. Med. Chem. 23, 466-470 (2015).
37. Lim, H. et al. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Biotechnol. Lett. In press, doi: 10.1007/s10529-016-2261-6 (2016).
38. Dong, W. et al. A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways. Sci. Rep. 4, 7237 (2014).
39. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. London. Ser. B, Biol. Sci. 147, 258-67 (1957).
40. Wang, Q. Y. et al. A translation inhibitor that suppresses dengue virus in vitro and in vivo. Antimicrob. Agents Chemother. 55, 4072-4080 (2011).
41. Xie, X. et al. Inhibition of dengue virus by targeting viral NS4B protein. J. Virol. 85, 11183-95 (2011).
42. Brandt, W. E., McCown, J. M., Top, F. H., Bancroft, W. H. & Russell, P. K. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect. Immun. 26, 534-541 (1979).
43. Kuczera, D. et al. Isolation of dengue virus serotype 4 genotype II from a patient with high viral load and a mixed Th1/Th17 inflammatory cytokine profile in South Brazil. Virol. J. 13, 93 (2016).
44. Gould, E. A. & Clegg, C. [Growth, titration and purification of togaviruses] virology: a practical approach in Virology: a practical approach. (1985).
45. Lanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J. & Vorndam, A. V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30, 545-551 (1992).
46. Böyum, A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. Suppl. 97, 77-89 (1968).
47. Silveira, G. F. et al. Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J. Virol. 85, 5374-83 (2011).